A smartphone app to help manage depression symptoms
Official title: Treating Depression on a Day-to-day Basis: Development of a Novel Clinical Tool for Physicians Based on a Smartphone Application, the SMART Project (Smartphones and Mood Disorders, an Application for Research and Treatment)
Run by Centre Hospitalier Charles Perrens, Bordeaux · NCT03678194 · Data updated 2026-11-12
This study is testing a smartphone app that helps people with depression track their symptoms and treatment to see if it can improve their care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Centre Hospitalier Charles Perrens, Bordeaux Government |
| Locations | 1 site (Bordeaux) |
| Status | Recruiting |
| Started | October 14, 2020 |
| Main results expected | December 31, 2024 |
| Study ends | December 31, 2026 |
| Registry record updated | March 16, 2026 |
| Trial ID | NCT03678194 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 65 who have recently started antidepressant treatment and meet the criteria for depression.
✕Probably not a fit
Patients with severe psychiatric disorders such as schizophrenia or bipolar disorder, or those unable to use the smartphone app due to cognitive or sensory impairments, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests and validates a smartphone application designed to monitor and understand daily symptoms of depression, medication adherence, and treatment effectiveness. By utilizing Ecological Momentary Assessment (EMA), the app collects real-time data from patients in their daily lives, aiming to identify factors that influence mood fluctuations and adherence to treatment. The goal is to enhance patient care by providing insights that can lead to tailored interventions based on individual patient needs.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management of depression by enabling personalized treatment strategies.
How similar studies have gone: Previous studies using similar EMA approaches in psychiatry have shown promising results in understanding mood disorders and improving treatment adherence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years; * Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of depression assessed by the Structured Clinical Interview; * Patients started their antidepressant treatment less than 5 days before inclusion; * Patient treated in an outpatient setting; * Patient informed of the diagnosis of his disease; * Informed patient with written consent. Exclusion Criteria: * A current mental or psychiatric impairment or disease (schizophrenia, bipolar disorder) that required psychotropic medication or inpatient treatment on a psychiatric ward; * A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features; * Cognitive deficit and not thus being able to comprehend the informed consent and study procedure; * Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy….); * Non-comprehension of the French language
Where it's running
-
Centre Hospitalier Charles PERRENS
Bordeaux, France Recruiting
Study contacts
- Study coordinator: David MISDRAHI, M.D
- Email: dmisdrahi@ch-perrens.fr
- Phone: +33(0)556563449
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Increasing daily physical activity to slow cognitive decline in alpha-synuclein disorders
This study will test whether using a motivational smartphone app to increase everyday physical activity can help slow cognitive decline in people aged 50–80 with isolated REM sleep behavior disorder (an early sign of alpha‑synuclein disease).
-
Virtual reality plus bilateral brain stimulation to improve arm and hand recovery after stroke
We will try combining virtual reality exercises with bilateral transcranial direct current stimulation (bi‑tDCS) to improve arm and hand movement in adults at least three months after a unilateral stroke.
-
Slow-SPEED: Can a smartphone app help people with prodromal Parkinson's stay more active?
This trial tests whether a remote smartphone app can help people with a LRRK2 G2019S or GBA1 N370S mutation increase daily activity and see if exercise might slow prodromal Parkinson's signs.
-
Portable EEG to triage suspected stroke patients in ambulances
This trial will test whether a portable dry‑electrode EEG headset (StrokePointer) can detect large vessel occlusion strokes in adults with suspected acute stroke so ambulance crews can take them directly to hospitals that perform thrombectomy.
-
Evaluating therapy for patients with minor strokes and large vessel occlusion
This study is testing different treatment options for patients with minor strokes caused by blocked large blood vessels to see which ones help them recover better.
-
Video call assessment for suspected stroke
This study tests if using video calls between neurologists and emergency responders can help quickly and accurately assess patients who might be having a stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.